CE
Therapeutic Areas
Nanoform Finland Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Multiple Partnered Small Molecule Programs | Various (Oncology, CNS, Infectious Disease) | Pre-clinical to Phase 3 |
| Biologics Nanoforming Platform | Platform for peptides & proteins | Research |
| Inhaled & Pulmonary Delivery Programs | Respiratory & systemic delivery | Pre-clinical |
Leadership Team at Nanoform Finland
EH
Edward Haeggström
Chief Executive Officer (CEO), Co-founder
AH
Albert Hæggström
Chairman of the Board, Co-founder
GC
Gianni Ciofani
Chief Business Officer (CBO)
TL
Tommi Lehtonen
Chief Financial Officer (CFO)
HA
Hélder A. Santos
Chief Scientific Officer (CSO)
EG
Erika Grönroos
VP, People & Culture
OK
Outi Kiviharju
VP, Legal & Compliance
SP
Sara Pereira
VP, Communications
RR
Riku Rantanen
Board Member
JP
John P. M. Brennan
Board Member